CUSIP: 88338H100
Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,462,253
-
Share change
-
-29,131
-
Total reported value
-
$8,759,050
-
Price per share
-
$1.60
-
Number of holders
-
47
-
Value change
-
-$222,353
-
Number of buys
-
10
-
Number of sells
-
19
Quarterly Holders Quick Answers
What is CUSIP 88338H100?
CUSIP 88338H100 identifies THTX - THERATECHNOLOGIES INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2020
-
Previous quarter:
Q4 2019
Recent filing periods for CUSIP 88338H100:
Institutional Holders of THERATECHNOLOGIES INC - COM (THTX) as of Q1 2020
As of 31 Mar 2020,
THERATECHNOLOGIES INC - COM (THTX) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,462,253 shares.
The largest 10 holders included
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC, BOSTON PRIVATE WEALTH LLC, CIBC World Markets Inc., STIFEL FINANCIAL CORP, MORGAN STANLEY, Federation des caisses Desjardins du Quebec, Hamilton Capital, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Swiss National Bank, and Advisor Group Holdings, Inc..
This page lists
47
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.